Diffusion Pharmaceuticals Inc

NASDAQ:DFFN   3:56:43 PM EDT
6.50
+0.73 (+12.65%)
Earnings Announcements

Diffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results, Provides Business Update

Published: 11/14/2022 21:53 GMT
Diffusion Pharmaceuticals Inc (DFFN) - Diffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update.
Diffusion Pharmaceuticals Inc - Ended Quarter With $25.9 Million in Cash, Cash Equivalents and Marketable Securities.
Diffusion Pharmaceuticals-cash, Cash Equivalents, Marketable Securities Will Fund Operating Expenses, Capital Expenditure Requirements Into Q1 of 2024.
Diffusion Pharmaceuticals Inc - Qtrly Loss per Share $1.37.